Practice question

Catalytic antibodies termed abzymes represent attempt to harness immune binding energy for chemical transformation similar to enzymes that accelerate reactions 10^10 fold by stabilizing transition state through complementarity. Natural enzymes use preorganized active site residues histidine, aspartate, serine triad precisely positioned via folding to provide general acid-base, nucleophile, oxyanion hole stabilization. Abzymes generated by immunization with stable transition-state analogue designed to mimic high energy tetrahedral intermediate of ester hydrolysis such as phosphonate monoester where P-O bond length resembles C-O tetrahedral geometry but non-hydrolyzable. Immune system selects B clones whose paratope complementary to analogue, somatically hypermutated variable regions can position Asp, His, Ser analogous to serine protease active site capable of promoting water activation and nucleophilic attack. Measured kcat enhancements 10^2 to 10^4 over background far below natural enzymes but proof of principle achieved for ester, amide, carbonate cleavage, Diels-Alder pericyclic, and beta-lactam hydrolysis that could degrade antibiotic resistance agents. Recombinant strategies introduce catalytic residues via site-directed mutagenesis, metal binding motifs for zinc dependent hydrolysis, or cofactor flavin to improve turnover. Abzymes remain conceptual prototype illustrating how binding energy can be converted into catalytic activation and potential for designer biocatalysts tailored to therapeutic prodrug activation.